Silvergate Pharmaceuticals' Series A - II Round

Silvergate Pharmaceuticals raised a round of funding on September 12, 2014. Investors include Frazier Healthcare.

Silvergate Pharmaceuticals is focused in the development and commercialization of innovative pediatric medications that offer greater dosing accuracy, safety, and availability. Silvergate Pharmaceutic…

Articles about Silvergate Pharmaceuticals' Series A - II Round: